Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
Isolation from the intestine of a healthy woman a novel bacteria strain that produces urolithins and development of a novel gut bacterial consortia comprising the mentioned novel bacterium and other bacteria wherein the consortia produce the mix of urolithins of metabotypes A or B, respectively, either in vitro or in vivo, including the newly characterized urolithin G.
In vitro method to assess the fertilizing capacity of spermatozoa and select those of better quality and with the ability to penetrate the zona pellucida (ZP) of the oocyte and fertilize it.
Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs), which can be used as a vaccines to generate immunity and protect against infections by these coronavirus.
A panel of high affinity nanobodies (Nb) binding to diverse SARS-CoV-2 RBD epitopes of spike protein, and a set of nanobody-derived neutralizing heavy chain antibodies (hcAbs) have been identified. They have potential as therapy against SRAS-CoV-2 for immunocompromised or non-responding to vaccines individuals.
New family of molecules with potent and selective antiviral activity in cellular models of infection by various coronaviruses such as SARS-CoV-2, MERS-CoV, hCoV-229E. They do not show cytotoxicity or activity against other viruses with RNA genome such as West Nile fever virus, dengue virus and vesicular stomatitis virus at relevant doses.
New procedure for obtaining cell spheroids by ultrasound from cell suspensions for in vitro studies, of special interest in the study of tumors without the need to use in vivo models.
System for the analysis of metagenomes and metatranscriptomes that integrates all analysis steps into a single platform, fast, user-friendly and on-site

Social Media